CompletedNCT02388659

Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas

Studying Oligodendroglioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas Southwestern Medical Center
Principal Investigator
Changho Choi, PhD
University of Texas Southwestern Medical Center
Intervention
3 Tesla scanning(device)
Enrollment
142 target
Eligibility
18 years · All sexes
Timeline
2014 – 2021

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02388659 on ClinicalTrials.gov

Other trials for Oligodendroglioma

Additional recruiting or active studies for the same condition.

See all trials for Oligodendroglioma →

← Back to all trials